Profile data is unavailable for this security.
About the company
EBOS Group Limited is a marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. The Company is a marketer and distributor of animal care brands. Its segments include Healthcare, Animal Care, and Corporate. The Healthcare segment includes sales of healthcare products in a range of sectors, own brands, retail healthcare, pharmacy, hospital and logistic services, and wholesale activities. The Animal Care segment includes sales of animal care products in a range of sectors, own manufactured and contract manufactured brands, retail, and wholesale activities. It sources and supplies a range of surgical, medical, and pharmaceutical products. Its Community Pharmacy business includes Symbion, ProPharma, Pharmacy Wholesalers Russells, TerryWhite Chemmart, Good Price Pharmacy Warehouse, healthSAVE, Ventura Health, Minfos, DoseAid, Intellipharm, Endeavour Consumer Health, and Red Seal. Its contract logistics include Healthcare Logistics and Clinect.
- Revenue in NZD (TTM)13.75bn
- Net income in NZD268.35m
- Incorporated1922
- Employees5.20k
- LocationEBOS Group LtdLevel 7, 737 Bourke Street,, DocklandsCHRISTCHURCH 3008AustraliaAUS
- Phone+64 3338-0999
- Fax+64 3339-5090
- Websitehttps://www.ebosgroup.com/
Mergers & acquisitions
| Acquired company | EBO:ASX since announced | Transaction value |
|---|---|---|
| Transmedic Pte Ltd | 3.93% | 21.75m |
| Svs Veterinary Supplies Ltd | 5.47% | 70.36m |
| Holder | Shares | % Held |
|---|---|---|
| AustralianSuper Pty Ltd.as of 29 May 2025 | 12.85m | 6.60% |
| Harbour Asset Management Ltd.as of 29 May 2025 | 9.69m | 4.98% |
| The Vanguard Group, Inc.as of 02 Jul 2025 | 6.55m | 3.36% |
| Accident Compensation Corp.as of 24 Jul 2024 | 5.57m | 2.86% |
| Capital Research & Management Co. (Global Investors)as of 31 Mar 2025 | 5.42m | 2.78% |
| Guardians of New Zealand Superannuationas of 30 Jun 2023 | 3.29m | 1.69% |
| ANZ New Zealand Investments Ltd.as of 24 Jul 2024 | 2.50m | 1.29% |
| Capital Research & Management Co. (World Investors)as of 31 Mar 2025 | 2.47m | 1.27% |
| Norges Bank Investment Managementas of 31 Dec 2024 | 2.31m | 1.18% |
| BlackRock Fund Advisorsas of 04 Jun 2024 | 2.04m | 1.05% |
